An interventional study of Phenytoin and Micro needling in Treatment of Striae Alba, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-09-25.
Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of this study is to evaluate the efficacy and safety of Microneedling with Phenytoin versus Microneedling alone for the Treatment of Striae alba.The study is a comparative study which will be carried on 30 patients with Striae alba. Each patient will receive four sessions three weeks apart of the following treatment: -Right side: striae on the right side will be treated by microneedling with depth (2 mm)with topical phenytoin 2% solution. -Left side: striae on the left side will be treated by microneedling alone with depth (2 mm) .
The follow up will be during each session and 1 months after the last session. For treated striae alba, Microneedling will be done under aseptic conditions using isopropyl alcohol 70%.
The aim of this study is to evaluate the efficacy and safety of Microneedling with Phenytoin versus Microneedling alone for the Treatment of Striae alba.The study is a comparative study which will be carried on 30 patients with Striae alba. Each patient will receive four sessions three weeks apart of the following treatment: -Right side: striae on the right side will be treated by microneedling with depth (2 mm)with topical phenytoin 2% solution. -Left side: striae on the left side will be treated by microneedling alone with depth (2 mm) .
The follow up will be during each session and 1 months after the last session. For treated striae alba, Microneedling will be done under aseptic conditions using isopropyl alcohol 70%.
All Patients will be evaluated during each session and 1 month after the last session.
All patients in this study will be subjected to the following:
Full history taking:
clinical Examination:
*General examination: to detect any associated dermatological or systemic disorders.
Local dermatological examination for detection of site, size, distribution and severity of stria alba .
The follow-up will include the following assessments: Evaluation by
1. Evaluation by Digital Photography Standardized high-resolution digital photographs taken before and after treatment under consistent lighting conditions. 2- Evaluation by Detect severity of striae by Imam, Nelva, Alviera score (INA score) 3-Evaluation of pain subject discomfort will assessed using a 10-centimeter Visual Analog Scale (VAS) on a scale from 0 cm (no pain) and 10 cm (pain as bad as it can be), 0-0.4 cm: No pain, 0.5-4.5 cm: Mild pain, 4.6-7.5 cm: Moderate pain, 7.6-10 cm: Severe pain
4 -Evaluation of Patient satisfaction (PS score) was recorded using the following scale: 0 (not satisfied), 1 (slightly satisfied), 2 (satisfied), 3 (very satisfied), 4 (extremely satisfied).
5-Patients will be assessed for any adverse effects including pain, edema, erosion, necrosis, and hyperpigmention.
Al-Azhar University is the lead sponsor of 532 studies on the registry; 173 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients with stria alba.
Exclusion Criteria:
Pregnancy or lactation.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
striae on the right side will be treated by microneedling with depth (2 mm)with topical phenytoin 2% solution. A 2% Phenytoin topical solution will be prepared by dissolving the accurate amount of Phenytoin sodium in purified water using a magnetic stirrer. 15% propylene glycol will be added to this solution as a cosolvent and a viscosity modifier. The formulation will be stirred using magnetic stirring up to complete dissolving. Finally, the prepared solution will be dispensed in an amber-colored glass bottle.
Drug: Phenytoin · Device: Micro needling
striae on the left side will be treated by microneedling alone with depth (2 mm).
Device: Micro needling
striae on the right side will be treated by microneedling with depth (2 mm)with topical phenytoin 2% solution. A 2% Phenytoin topical solution will be prepared by dissolving the accurate amount of Phenytoin sodium in purified water using a magnetic stirrer. 15% propylene glycolwill be added to this solution as a cosolvent and a viscosity modifier. The formulation will be stirred using magnetic stirring up to complete dissolving. Finally, the prepared solution will be dispensed in an amber-colored glass bottle.
striae on the left side will be treated by microneedling alone with depth (2 mm) .
Change in INA score of striae alba between treatment sides
Change in the INA score of striae alba from baseline to after completion of the four treatment sessions for each treatment side. The change in INA score will be compared between the right side treated with micro needling plus topical phenytoin and the left side treated with micro needling alone.,
Time frame: baseline (before Session 1) and Week 9 (after completion of Session 4)
Change in INA score of striae Alba between treatment sides.
\- The change in (INA) score of striae alba from baseline and 1 month after the last session for each treatment side. The change in INA score will be compared between the right side treated with microneedling plus topical phenytoin and the left side treated with microneedling alone.
Time frame: Baseline (before Session 1), and 1 month after the last treatment session(weak 13).
Change in pain score
Pain intensity will be assessed using a visual analogue scale (VAS)on a scale from 0 cm (no pain) and 10 cm (pain as bad as it can be), 0-0.4 cm: No pain, 0.5-4.5 cm: Mild pain, 4.6-7.5 cm: Moderate pain, 7.6-10 cm: Severe pain during each treatment session for both treatment sides. Pain scores will be compared between the right side treated with microneedling plus topical phenytoin and the left side treated with microneedling alone.
Time frame: During each treatment session at Baseline (before Session 1), Week 3 (before Session 2), Week 6 (before Session 3), and Week 9 (before Session 4).
Change in Patient Satisfaction (PS) Score
Patient satisfaction will be assessed using the Patient Satisfaction (PS) score 0 (not satisfied), 1 (slightly satisfied), 2 (satisfied), 3 (very satisfied), 4 (extremely satisfied) after treatment( weak 9), and 1 month after the last treatment session for each treatment side. Changes in PS scores will be compared between the right side treated with micro needling plus topical phenytoin and the left side treated with micro needling alone.
Time frame: Baseline, after treatment at fourth session(weak 9) , and 1 month after the last treatment session(weak13).
Plan to share: No
No publications or documents are linked to this record.
Ran from Dec 2025 to primary completion in May 2026, 5 months.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Phenytoin